[
  {
    "ts": "2026-01-14T07:37:10+00:00",
    "headline": "Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs",
    "summary": "The GLP-1 giants are the first to try out this new model, but more companies may follow.",
    "url": "https://www.pharmavoice.com/news/lilly-novo-direct-employer-drug-cost-pbm-consumer/809575/",
    "source": "Pharma Voice",
    "provider": "yfinance",
    "raw": {
      "id": "4db4d2bb-ad4e-395e-b77e-aa626692ff12",
      "content": {
        "id": "4db4d2bb-ad4e-395e-b77e-aa626692ff12",
        "contentType": "STORY",
        "title": "Lilly, Novo test direct-to-employer approach that could cut out PBMs and lower costs",
        "description": "",
        "summary": "The GLP-1 giants are the first to try out this new model, but more companies may follow.",
        "pubDate": "2026-01-14T07:37:10Z",
        "displayTime": "2026-01-14T07:37:10Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharma_voice_330/3b2c31d041e3be1658c67634d44630da",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Health insurer Molina Healthcare reported second-quarter results on July 27, 2022.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hnFyQHoVgPhLIfqyHtZ7mA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharma_voice_330/3b2c31d041e3be1658c67634d44630da.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/U28tfaLGLsJT_IbxwN3OmQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharma_voice_330/3b2c31d041e3be1658c67634d44630da.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharma Voice",
          "url": "https://www.pharmavoice.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmavoice.com/news/lilly-novo-direct-employer-drug-cost-pbm-consumer/809575/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/lilly-novo-test-direct-employer-073710828.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVO"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-14T13:00:20+00:00",
    "headline": "Nvidia Eyes First Breakout Of 2026. These Clues — And An Innovative Deal With Eli Lilly — Bode Well.",
    "summary": "Now set to collaborate with Eli Lilly to develop drugs in the AI era, Nvidia looks to trigger a new climb.",
    "url": "https://www.investors.com/research/breakout-stocks-technical-analysis/nvidia-stock-eyes-first-breakout-of-2026-with-eli-lilly-ai-collaboration/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "29d673eb-8756-34b8-b3de-fb7f5eab5629",
      "content": {
        "id": "29d673eb-8756-34b8-b3de-fb7f5eab5629",
        "contentType": "STORY",
        "title": "Nvidia Eyes First Breakout Of 2026. These Clues — And An Innovative Deal With Eli Lilly — Bode Well.",
        "description": "",
        "summary": "Now set to collaborate with Eli Lilly to develop drugs in the AI era, Nvidia looks to trigger a new climb.",
        "pubDate": "2026-01-14T13:00:20Z",
        "displayTime": "2026-01-14T13:00:20Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/29d673eb-8756-34b8-b3de-fb7f5eab5629/nvidia-eyes-first-breakout-of.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/f5161cefefbf4b4e513a9ed2c34cd885",
          "originalWidth": 1000,
          "originalHeight": 563,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3Qspy2SfrKIYEshxHRa3_A--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f5161cefefbf4b4e513a9ed2c34cd885.cf.webp",
              "width": 1000,
              "height": 563,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/duRT6Dnmz77p83MsqEDWsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/f5161cefefbf4b4e513a9ed2c34cd885.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/research/breakout-stocks-technical-analysis/nvidia-stock-eyes-first-breakout-of-2026-with-eli-lilly-ai-collaboration/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "NVDA"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]